Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
ME Pichichero, MB Rennels, KM Edwards, MM Blatter… - Jama, 2005 - jamanetwork.com
ContextIncreasing reports of pertussis among US adolescents, adults, and their infant
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b …
U Heininger, DTPHBV The, R Sänger, JM Jacquet… - Vaccine, 2007 - Elsevier
The immunogenicity and reactogenicity of booster vaccination with GSK Biologicals'
hexavalent DTPa-HBV-IPV/Hib vaccine was assessed in toddlers aged 12–18 months …
hexavalent DTPa-HBV-IPV/Hib vaccine was assessed in toddlers aged 12–18 months …
Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered …
U Zimmermann, G Gavazzi, P Richard, C Eymin… - Vaccine, 2013 - Elsevier
BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …
The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …
EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
The present and future control of pertussis
JD Cherry - Clinical Infectious Diseases, 2010 - academic.oup.com
Currently, there are 2 tetanus and reduced antigen content diphtheria and acellular
pertussis vaccines (Tdap vaccines; called dTpa in Europe) available for the immunization of …
pertussis vaccines (Tdap vaccines; called dTpa in Europe) available for the immunization of …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …
FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined,(PEDIARIX) for use in …
Centers for Disease Control and … - MMWR. Morbidity …, 2003 - pubmed.ncbi.nlm.nih.gov
On December 13, 2002, the US Food and Drug Administration (FDA) licensed a combined
diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), hepatitis B …
diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), hepatitis B …
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and …
NP Klein, R Abu-Elyazeed, B Cheuvart… - Human Vaccines & …, 2019 - Taylor & Francis
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated
poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further …
poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis …
L Barreto, R Guasparini, W Meekison, F Noya, L Young… - Vaccine, 2007 - Elsevier
Persistence of antibodies following a single dose of Tdap vaccine (tetanus, diphtheria, and
five-component acellular pertussis vaccine for use in individuals past childhood) was …
five-component acellular pertussis vaccine for use in individuals past childhood) was …